true

BD UltraSafe Plus™ 2.25 mL Passive Needle Guard

Enabling the delivery of complex biologics with ergonomic solutions

ultrasafe plus banner 201771720
Loading
Overview

The BD UltraSafe Plus™ 2.25 mL Passive Needle Guard enables the delivery of complex biologics with ergonomic solutions.  Featuring one-handed, passive activation, the BD UltraSafe Plus™ offers bio-pharmaceutical companies ergonomic delivery systems for manual injection* in 1 ML and 2.25 ML formats.

The BD UltraSafe Plus™ is usable by patients, caregivers and HCPs and supports viscous drug delivery via manual injection. ‡,†

 

Features and Benefits

BD UltraSafe Plus™ 2.25 mL Passive Needle Guard Features

  • Large drug inspection window1
  • Optimal add-on finger flange2
  • Ergonomic plunger head

BD UltraSafe Plus™ 2.25 mL Passive Needle Guard Benefits

  • One-handed, passive activation.
  • Offers bio-pharmaceutical companies ergonomic delivery systems for manual injection* in 1 mL and 2.25 mL formats
  • Ergonomic design aims to support injection comfort, ease of use.
  • Provides confidence against needlestick injury.
  • Is usable by patients, caregivers, and HCPs.
  • Supports viscous drug delivery‡,†3 via manual injection.
  • Meets sharps injury protection requirements.4

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Endnotes

*When used in combination with prefilled syringe

up to 9cp with the 1mL

up to 30cp with the 2.25mL

References
  1. Designed to enable drug visualization at low fill volume: 0.25 mL for BD UltraSafe Plus™ 1 mL and 0.6 mL for BD UltraSafe Plus™ 2.25 mL
  2. The built-in finger flange (not pictured) is extended for BD UltraSafe Plus™ in comparison to BD UltraSafe Passive™ needle guard
  3. BD UltraSafe Plus™ 1 mL is marketed with up to 9 cP solutions; BD UltraSafe Plus™ 2.25 mL is validated for delivery of up to 30 cP solutions
  4. ISO 23908:2011 Sharps Injury Protection and FDA guidance on Sharps Injury Prevention Features

BD Expertise in Passive Needle Guard

  • More than one billion units of BD UltraSafe™ Needle Guardshave been sold as of 2020.2
  • History of commercial use by healthcare providers and patients, in a variety of therapeutic areas.
  • Validated for assembly with extensive installed base of assembly machines at Contract Manufacturing Organizations (CMOs) and pharma.
  • BD UltraSafe Passive™ Needle Guard and BD UltraSafe Plus™ Passive Needle Guard are approved for use with more than 40 drugs/brands.

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

References

  1. Includes both BD UltraSafe Passive™ and BD UltraSafe Plus™ passive needle guards
  2. BD sales dataal Sciences COE.

Related Product Families

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Resources

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form: